Gene polymorphisms associated with diminished activity of 5,10-methylenetetrahydrofolate reductase do not explain the clinical manifestations of cobalamin deficiency [1]

British Journal of Haematology

Volumn 120, Issue 5, 2003, Pages 907-909

  Carmel, Ralph ^a   Pullarkat, Vinod ^b  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cobalamin deficiency; Folate; Megaloblastic anaemia; Methylenetetrahydrofolate reductase; Neurological dysfunction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LETTER; MALE; NEUROLOGIC DISEASE; PERNICIOUS ANEMIA; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

ADULT; AGED; ANEMIA, PERNICIOUS; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; VITAMIN B 12 DEFICIENCY;

EID: 0037337445     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04151_1.x     Document Type: Letter

References (7)

1. Carmel, R. & Rosenblatt, D.S. (2002) Disorders of cobalamin and folate metabolism. In: Blood. Principles and Practice of Hematology, 2nd edn (ed. by R.I. Handin, S.E. Lux & T.P. Stossel), chap. 45. Lippincott Williams & Wilkins, Philadelphia.
2. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.I.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuvel, L.P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111-113.
3. Healton, E.B., Savage, D.G., Brust, J.C., Garrett, T.J. & Lindenbaum, J. (1991) Neurologic aspects of cobalamin deficiency. Medicine, 70, 229-245.
4. McAndrew, P.E., Brandt, J.T., Pearl, D.K. & Prior, T.W. (1996) The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thrombosis Research, 83, 195-198.
5. van der Put, N.M.J., Gabreëls, F., Stevens, E.M.B., Smeitink, J.A.M., Trijbels, F.J.M., Eskes, T.K.A.B., van den Heuvel, L.P. & Blom, H.J. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? American Journal of Human Genetics, 62, 1044-1051.
6. Weisberg, I., Tran, P., Christensen, B., Sibani, S. & Rozen, R. (1998) A second polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Molecular Genetics and Metabolism, 64, 169-172.
7. Weisberg, I.S., Jacques, P.F., Selhub, J., Bostom, A.G., Chen, Z., Ellison, R.C., Eckfeldt, J.H. & Rozen, R. (2001) The 1298A → C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis, 156, 409-415.